RankAlpha logo
Back to Rankings

KRRO

Korro BioF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart

Operating peers and competitors

Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.

Loading market evidence...

Research comparisons do not establish forecast usefulness or trading returns.

Compare shared product markets

Membership only; no portfolio weights or estimated losses.

+
Peers tracked
9
U.S. public peers
Grade Position
Below peers
vs peer average
KRRO vs peer average
39/100
KRRO vs. peer average (F vs. D)
Grade spread
B 1 · C 1 · D 1 · F 6
Graded peers loaded
Coverage
9 graded
100% of tracked

Peer overview

WVE is the first available peer comparator.

Direct AATD and delivery-modality comparator: Wave's WVE-006 and Korro's KRRO-111 are subcutaneously delivered, GalNAc-conjugated RNA-editing oligonucleotides. Wave reported patient data from its RestorAATion-2 trial in May 2026, whereas KRRO-111's cited results remain in mice. This is a useful clinical-translation and competitive benchmark, not a transferable valuation multiple. Company source: https://ir.wavelifesciences.com/news-releases/news-release-details/wave-life-sciences-announces-positive-update-restoraation-2

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerWVEWave Life Sciences
KRRO
Korro Bio
WVE
Wave Life Sciences
Grade
F
F
Momentum
10
4
Value
41
41
Sentiment
42
44
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive

Grade position vs WVE

KRRO / WVE
Grade Position
Below peers
KRRO vs. peer average (F vs. D)
39/100
Momentum
10
KRRO
Value
41
KRRO
Sentiment
42
WVE

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs KRRO
1
WVE
WVE
F
20/100
Even
2
PRQR
PRQR
F
20/100
Even
3
XGN
Exagen Inc Common
F
20/100
Even
4
PEPG
PepGen Inc Common
F
20/100
Even
5
IVVD
Invivyd Inc Common
C
60/100
+2
WVE is the first peer returned for this comparison set.